HD Insights
  • Home
  • About HD Insights
  • Contact
  • Back to HSG
HD Insights
  • Home
  • About HD Insights
  • Contact
  • Back to HSG

Meet the Investigator

Posted by Steve Bucciarelli - April 1, 2013
VITAL SIGNS NAME: Michael Hayden, CM, OBC, MB, ChB, PhD, FRCP(C), FRSC CURRENT Dr. Michael…
Read More

Meet the Company

Posted by Steve Bucciarelli - April 1, 2013
              VITAL SIGNS NAME: Teva Pharmaceutical Industries, Ltd. HEADQUARTERS:…
Read More

HD Insights Volume 6 (PDF)

Posted by Steve Bucciarelli - February 23, 2013
[pdf-embedder url=”https://huntingtonstudygroup.org/wp-content/uploads/2016/05/vol-6-winter-2013.pdf”]
Read More

HD Insights Volume 3 (PDF)

Posted by Steve Bucciarelli - November 1, 2012
[pdf-embedder url=”https://huntingtonstudygroup.org/wp-content/uploads/2016/05/vol-3-fall-2012.pdf”]
Read More

An Interview with Dr. Nancy Wexler: Discovering the Huntington Disease Gene

Posted by Steve Bucciarelli - September 1, 2012
By: Kristin Darwin One morning in 1968, Dr. Nancy Wexler’s mother, Leonore Wexler, had jury…
Read More

Meet the Company

Posted by Steve Bucciarelli - September 1, 2012
        VITAL SIGNS NAME: Isis Pharmaceuticals HEADQUARTERS: Carlsbad, California STOCK PRICE AS…
Read More

Research Around the World: Chile

Posted by Steve Bucciarelli - September 1, 2012
Alleviating Secretory Pathway Stress in Huntington Disease By: Rene Vidal, PhD and Claudio Hetz, PhD…
Read More

Highlights from the CHDI HD Therapeutics Conference

Posted by Steve Bucciarelli - September 1, 2012
By: Lise Munsie, PhD At the 7th Annual CHDI HD Therapeutics Conference in Palm Springs,…
Read More

The Use of Antisense Oligonucleotides for Gene Silencing

Posted by Steve Bucciarelli - September 1, 2012
By: Emily Mitchell Sontag, PhD Huntington disease (HD) is caused by a single gene mutation…
Read More

Research Round-Up

Posted by Steve Bucciarelli - September 1, 2012
By: Lise Munsie, PhD In the beginning… In the past year, researchers have published on…
Read More

Posts navigation

Previous 1 … 22 23 24 25 Next

About HD Insights

Our mission is to promote, disseminate, and facilitate research on Huntington’s disease. To fulfill this mission, we are guided by an outstanding editorial board that includes representatives from three continents, academia, industry, and the HD community.

More Information

Past Issues

  • Vol. 28
  • Vol. 27
  • Vol. 26
  • Vol. 25
  • Vol. 24
  • Vol. 23
  • Vol 22
  • Vol 21
  • Vol 20
  • Vol 19
  • Vol. 18
  • Vol. 17

Navigation

  • Home
  • HD Insights Acknowledgements
  • Contact Us

Recent Posts

  • From the Editor: COMMUNITY IS EVERYTHING
  • HD Research Profiles (Spring 2023)
  • Featured Story: Time to Make the Call from Behavioral Symptoms
  • Featured Story: Psychiatric Perspectives on Juvenile Huntington’s Disease
  • Featured Story: Understanding the Risk to Empower Patients
  • Featured Story: Heard! Second FDA Patient Listening Session Focuses on JHD
  • Featured Story: Amping Up the Work in Rare Disease
  • Featured Story: Standing Up for Juvenile-Onset HD
  • HSG Closing Thoughts

Contact HSG

Huntington Study Group
95 Allens Creek Road, Building 1, Suite 132
Rochester, NY 14618, USA

Toll Free (North America):
800-487-7671

Fax: 585-672-9912

Email: info@hsglimited.org

SMARTSite by Site Hub 2018

  • Home
  • HD Insights Acknowledgements
  • Contact Us